MRPL52 and breast carcinoma: MRPL52 regulates hypoxia-induced apoptotic resistance and metastatic initiation of breast cancer cells by facilitating PINK1/Parkin-dependent mitophagy and transactivating the reactive oxygen species (ROS)-Notch1-Snail pathway, respectively.